{"name":"Rene Kahn","slug":"rene-kahn","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"6-week olanzapine double blind treatment","genericName":"6-week olanzapine double blind treatment","slug":"6-week-olanzapine-double-blind-treatment","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"6-week olanzapine double blind treatment","genericName":"6-week olanzapine double blind treatment","slug":"6-week-olanzapine-double-blind-treatment","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNTi11UmF0SnN5UmtzdGNIN1ZnZG56U3BmeFM2MWQ2WTBLNlRGcDRpaUdDSmlsckM1WkVTcTZFN3lRMkMweUlLNHItbDdjaXdIWVgwMUF1VG85YjFpemxFRnRSTzhMSUNkeG9iZXZLTHB0eFZNWndyVU1FQVpFNXhsT3I1bHhSRjNUMXlfLXg4RTRrREdfalIzZ01TYXY5RVpkT2pLdE96dWJ4Zk1rbDFsT2h0b0g1OXRKaG93eg?oc=5","date":"2024-12-04","type":"regulatory","source":"Psychiatrist.com","summary":"Long-Term Safety, Tolerability, and Durability of Treatment Effect of Olanzapine and Samidorphan: Results of a 4-Year Open-Label Study - Psychiatrist.com","headline":"Long-Term Safety, Tolerability, and Durability of Treatment Effect of Olanzapine and Samidorphan: Results of a 4-Year Op","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE0wUGpONWZ6VEVuTF9zNVp6QXJNOUlrTkhYeTBrYW5KemRBUXRoY215OEhyX2JRTHNMWmpKVHZsV3gybDNZXzBESW9CTjR4ZURNM3hQUFQyY25XaHp2VDNENXNSbnNDTjM0SGFBVTVYTTJEYkV2cEE?oc=5","date":"2020-08-14","type":"trial","source":"Psychiatry Online","summary":"Effects of Olanzapine Combined With Samidorphan on Weight Gain in Schizophrenia: A 24-Week Phase 3 Study - Psychiatry Online","headline":"Effects of Olanzapine Combined With Samidorphan on Weight Gain in Schizophrenia: A 24-Week Phase 3 Study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTE9NT3pEUHd3QXFyNjJ5VVFrZkJ4ZHQ1QjR2QnZHdl91RlpsU3ZOWFF5aC13c2R2OWJTbThhVXpfMFBhY0prZ0FUU0h0ZnJRbURQTGtRRmZUNWptR2FGbWp4UlVPMGtmSmZ5eXJzdWdKREk?oc=5","date":"2020-04-01","type":"pipeline","source":"Psychiatry Online","summary":"On the Origins of Schizophrenia | American Journal of Psychiatry - Psychiatry Online","headline":"On the Origins of Schizophrenia | American Journal of Psychiatry","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxOSDBDYUFQVndDVFVYQUswbnVFUkVPcnM1Y2ZZeGczREFweW5zaVYtcUFwSHpRbVZ3TWtNTHJOWDBpR1c1WUY1U3NHVm1CZDM2R3dnM283Y2tWZUFDVm00NlRKU2VTTWtSNTdSa3FYM1pXbDdHczhaXzdfME53cEZVbWdYZHpTNjN0UFNHM3hfT0RSSkJ2M3c?oc=5","date":"2017-05-12","type":"pipeline","source":"Columbia University Department of Psychiatry","summary":"Benefits of Antipsychotics Outweigh Risks, Find Experts - Columbia University Department of Psychiatry","headline":"Benefits of Antipsychotics Outweigh Risks, Find Experts","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}